Literature DB >> 22727192

Islet-1 gene delivery improves myocardial performance after experimental infarction.

Aya Barzelay1, Edith Hochhauser, Michal Entin-Meer, Yelena Chepurko, Einat Birk, Arnon Afek, Iris Barshack, Lidya Pinhas, Yulia Rivo, Jeremy Ben-Shoshan, Sofia Maysel-Auslender, Gad Keren, Jacob George.   

Abstract

OBJECTIVE: The LIM-homeobox transcription factor Isl1 plays a crucial role during heart embryogenesis and later on gives rise to adult resident cardiac stem cells. In this study, we aimed to discover new extra cardiac populations of Isl1 stem cells. We then investigated endogenous Isl1 kinetics after myocardial infarction (MI), and the effect of intra-myocardial gene transfer of naked DNA encoding Isl1 on functional recovery after MI.
METHODS: We used the transgenic mice Isl1/cre/Z/EG for lineage tracing of extra cardiac Isl1 stem cells. Non transgenic mice were used to study Isl1 kinetics post-MI by RT-PCR and FACS analysis. MI was induced in non transgenic mice by permanent ligation of the left anterior descending coronary artery (LAD). Naked DNA encoding Isl1 was injected to the peri-infarct region. Evaluation of cardiac performance was conducted by echocardiogram. Analysis of myocardial fibrosis and number of vessels was performed on histological cryosections. RESULTS AND
CONCLUSIONS: Isl1 gives rise to subpopulations of progenitors in both the bone marrow and spleen, and is re-expressed in the spleen and left ventricle following MI. Intramyocardial gene transfer of Isl1 to the border zone of the infarcted hearts resulted in partial salvage of left ventricular function, enhanced vascularization, and reduced myocardial fibrosis. The Isl1 gene appears to be an attractive reparative target for future management of myocardial dysfunction.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22727192     DOI: 10.1016/j.atherosclerosis.2012.05.025

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

Review 1.  Developmental origin and lineage plasticity of endogenous cardiac stem cells.

Authors:  Maria Paola Santini; Elvira Forte; Richard P Harvey; Jason C Kovacic
Journal:  Development       Date:  2016-04-15       Impact factor: 6.868

2.  Wnt-promoted Isl1 expression through a novel TCF/LEF1 binding site and H3K9 acetylation in early stages of cardiomyocyte differentiation of P19CL6 cells.

Authors:  Huafei Lu; Yanming Li; Yang Wang; Yinan Liu; Weiping Wang; Zhuqing Jia; Ping Chen; Kangtao Ma; Chunyan Zhou
Journal:  Mol Cell Biochem       Date:  2014-03-08       Impact factor: 3.396

3.  BMSCs overexpressed ISL1 reduces the apoptosis of islet cells through ANLN carrying exosome, INHBA, and caffeine.

Authors:  Ying Wang; Jiang-Wei Zhang; Jing-Wen Wang; Jia-Le Wang; Shu-Cong Zhang; Rui-Yang Ma; Jing Zhang; Yang Li; Pei-Jun Liu; Wu-Jun Xue; Jin Zheng; Xiao-Ming Ding
Journal:  Cell Mol Life Sci       Date:  2022-10-03       Impact factor: 9.207

4.  Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNA.

Authors:  Kathy O Lui; Lior Zangi; Eduardo A Silva; Lei Bu; Makoto Sahara; Ronald A Li; David J Mooney; Kenneth R Chien
Journal:  Cell Res       Date:  2013-09-10       Impact factor: 25.617

Review 5.  The Role of MicroRNAs in Cardiac Stem Cells.

Authors:  Nima Purvis; Andrew Bahn; Rajesh Katare
Journal:  Stem Cells Int       Date:  2015-01-31       Impact factor: 5.443

6.  Role of endogenous insulin gene enhancer protein ISL-1 in angiogenesis.

Authors:  Si-Qi Xiong; Hai-Bo Jiang; Yan-Xiu Li; Hai-Bo Li; Hui-Zhuo Xu; Zhen-Kai Wu; Wei Zheng; Xiao-Bo Xia
Journal:  Mol Vis       Date:  2016-12-02       Impact factor: 2.367

7.  ISL1 overexpression enhances the survival of transplanted human mesenchymal stem cells in a murine myocardial infarction model.

Authors:  Qiuling Xiang; Yan Liao; Hua Chao; Weijun Huang; Jia Liu; Haixuan Chen; Dongxi Hong; Zhengwei Zou; Andy Peng Xiang; Weiqiang Li
Journal:  Stem Cell Res Ther       Date:  2018-02-26       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.